We are live on ! Find out more
BCM

BTR Capital Management Portfolio holdings

AUM $641M
1-Year Est. Return 9.05%
This Fund
S&P 500
This Quarter Est. Return
-11.68%
1 Year Est. Return
-9.05%
3 Year Est. Return
+35.04%
5 Year Est. Return
+68.26%
10 Year Est. Return
AUM
$475M
AUM Growth
-$100M
Cap. Flow
-$25.5M
Cap. Flow %
-5.37%
Top 10 Hldgs %
31.08%
Holding
184
New
12
Increased
29
Reduced
93
Closed
22

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$3.67M
2
KMI icon
Kinder Morgan
KMI
+$3.21M
3
WY icon
Weyerhaeuser
WY
+$2.89M
4
CVS icon
CVS Health
CVS
+$2.83M
5
JNJ icon
Johnson & Johnson
JNJ
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 14.29%
2 Technology 12.37%
3 Financials 11.06%
4 Industrials 9.4%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$19.4M 4.08%
190,959
-9,601
-5% -$1.03M
JPM icon
2
JPMorgan Chase
JPM
$939B
$15.8M 3.32%
161,506
-5,560
-3% -$592K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.91T
$14.9M 3.15%
286,060
-11,180
-4% -$604K
AAPL icon
4
Apple
AAPL
$4.89T
$14.9M 3.14%
377,884
-12,708
-3% -$616K
PEP icon
5
PepsiCo
PEP
$186B
$14.6M 3.07%
131,775
-10,255
-7% -$1.16M
DIS icon
6
Walt Disney
DIS
$165B
$14.1M 2.98%
128,910
-5,380
-4% -$612K
AWK icon
7
American Water Works
AWK
$26.3B
$14M 2.94%
153,774
-6,360
-4% -$581K
V icon
8
Visa
V
$677B
$13.8M 2.9%
104,293
-4,366
-4% -$603K
TMO icon
9
Thermo Fisher Scientific
TMO
$211B
$13.5M 2.84%
60,302
-3,525
-6% -$827K
CVX icon
10
Chevron
CVX
$388B
$12.7M 2.67%
116,448
-3,637
-3% -$421K
CCI icon
11
Crown Castle
CCI
$32.7B
$12.1M 2.54%
111,199
-5,135
-4% -$564K
MRK icon
12
Merck
MRK
$324B
$11.5M 2.41%
157,198
-5,989
-4% -$423K
LOW icon
13
Lowe's Companies
LOW
$116B
$11M 2.32%
119,268
+1,301
+1% +$125K
HACK icon
14
Amplify Cybersecurity ETF
HACK
$2.63B
$10.5M 2.21%
311,135
-12,845
-4% -$460K
QCOM icon
15
Qualcomm
QCOM
$176B
$10.4M 2.19%
182,436
-13,156
-7% -$799K
JNJ icon
16
Johnson & Johnson
JNJ
$635B
$10.3M 2.17%
79,996
-19,672
-20% -$2.74M
ORCL icon
17
Oracle
ORCL
$331B
$10.1M 2.13%
223,537
-9,070
-4% -$435K
RTX icon
18
RTX Corp
RTX
$287B
$9.19M 1.94%
137,166
-8,321
-6% -$653K
IHI icon
19
iShares US Medical Devices ETF
IHI
$3.02B
$9.18M 1.93%
275,718
-8,334
-3% -$289K
PFE icon
20
Pfizer
PFE
$140B
$8.9M 1.87%
214,994
-13,295
-6% -$552K
PG icon
21
Procter & Gamble
PG
$343B
$8.39M 1.77%
91,238
-15,620
-15% -$1.4M
ABT icon
22
Abbott
ABT
$180B
$8.05M 1.69%
111,246
-4,770
-4% -$335K
AL
23
DELISTED
Air Lease Corp
AL
$7.25M 1.53%
239,971
-13,480
-5% -$514K
XBI icon
24
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$7.15M 1.5%
99,601
-3,515
-3% -$283K
CNK icon
25
Cinemark Holdings
CNK
$3.82B
$7.09M 1.49%
197,960
-10,950
-5% -$433K

Similar funds

BTR Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, BTR Capital Management held 184 positions worth $475M, down 17% from $575M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

BTR Capital Management withdrew a net $25.5M in Q4 2018, closing 22 positions and reducing 93 holdings. Its most notable exit was APA Corp, an estimated $1.03M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, BTR Capital Management opened a new position in Alerian MLP ETF worth $2.77M.

  • BTR Capital Management's largest Q4 2018 buy was Alerian MLP ETF: 63,394 shares worth $2.77M.
  • BTR Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $3.04M increase.
  • BTR Capital Management's biggest Q4 2018 reduction was Ventas, cutting an estimated $3.67M.
  • BTR Capital Management fully exited APA Corp in Q4 2018, selling an estimated $1.03M.
  • BTR Capital Management's ten largest holdings make up 31% of its $475M portfolio in Q4 2018.
  • BTR Capital Management opened 12 new positions and closed 22 in Q4 2018.
  • BTR Capital Management's portfolio value fell 17% quarter-over-quarter to $475M.

Based on BTR Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.